“Genotype-Related Efficacy and Adverse Effects of Selective Serotonin Reuptake Inhibitors in Patients With Major Depressive Disorder”. Precision Medicine Communications, vol. 2, no. 1, June 2022, pp. 27-42, https://doi.org/10.55627/pmc.002.01.0044.